Prolonged Survival on PARP Inhibitor Therapy In a Patient With Stage IV Non-small Cell Lung Cancer: A Case Report. Archives of Clinical and Medical Case Reports, v. 3, n. 2, p. 59–61, 21 Mar.2019.